A valid self-help tool to measure the role of spousal support in the care of persons with diabetes mellitus
Tóm tắt
Family members, especially the spouse, could reinforce or discourage lifestyle/behavioral change to manage one’s diabetes. This study was done to describe and validate a scale that measured the spouse’s support specific to the management of diabetes. A questionnaire that embodies various domains of self-care was developed and administered to both the patient and their spouse. The total score was used to validate the scale, using glycemic control (HbA1c) as the criterion. Various measures of validity with their respective 95% CI were calculated. There were 249 eligible couples. Mean age of those with diabetes was 57.4 ± 11.3 years. Duration of diabetes ranged from less than a year to 40 years, with a mean duration of 12.0 ± 8.3 years. The spousal support score was negatively correlated to HbA1c (r = − 0.25, p < 0.0001) and had a significant discriminatory power (AUC: 0.62 (0.55–0.69)) based on ROC curve. Those who scored greater than 13 were considered to be supportive based on Youden’s Index J. Using this cut-off, the likelihood ratio was significantly high [LR + (95% CI): 1.7 (1.4–2.2)] and those who had poor support from their spouses had 2.4 times the odds of having uncontrolled diabetes compared to those with good spousal support [OR (95% CI):2.4 (1.3–4.5)], irrespective of other factors. The internal consistency of the questions used for this multidimensional scale was appropriately low (Cronbach’s alpha = 0.67). Self-care was constant across groups. Being clearly associated with glycemic control, the Spousal Support Scale can be used in the clinic for health education and as a self-assessment tool by the couple.
Tài liệu tham khảo
Campbell DJ, Sargious P, Lewanczuk R, McBrien K, Tonelli M, Hemmelgarn B, et al. Use of chronic disease management programs for diabetes: in Alberta’s primary care networks. Can Fam Physician. 2013;59(2):e86-92.
Ciemins EL, Coon PJ, Fowles JB, Min SJ. Beyond health information technology: critical factors necessary for effective diabetes disease management. J Diabetes Sci Technol. 2009;3(3):452–60.
Every B. Better for ourselves and better for our patients: chronic disease management in primary care networks. Healthc Q. 2007;10(3):70–4.
Güner TA, Coşansu G. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus. Prim Care Diabetes. 2020;14(5):482–7.
Huh J, Liu LS, Neogi T, Inkpen K, Pratt W. Health vlogs as social support for chronic illness management. ACM Trans Comput Hum Interact. 2014;21(4).
Wilson PM, Brooks F, Procter S, Kendall S. The nursing contribution to chronic disease management: a case of public expectation? Qualitative findings from a multiple case study design in England and Wales. Int J Nurs Stud. 2012;49(1):2–14.
Yasmin F, Ali L, Banu B, Rasul FB, Sauerborn R, Souares A. Understanding patients’ experience living with diabetes type 2 and effective disease management: a qualitative study following a mobile health intervention in Bangladesh. BMC Health Serv Res. 2020;20(1):29.
Plumb J, Weinstein LC, Brawer R, Scott K. Community-based partnerships for improving chronic disease management. Prim Care. 2012;39(2):433–47.
Johansson T, Keller S, Winkler H, Ostermann T, Weitgasser R, Sönnichsen AC. Effectiveness of a peer support programme versus usual care in disease management of diabetes mellitus type 2 regarding improvement of metabolic control: a cluster-randomised controlled trial. J Diabetes Res. 2016;2016:3248547.
Rosland AM, Piette JD. Emerging models for mobilizing family support for chronic disease management: a structured review. Chronic Illn. 2010;6(1):7–21.
Primomo J, Yates BC, Woods NF. Social support for women during chronic illness: the relationship among sources and types to adjustment. Res Nurs Health. 1990;13(3):153–61.
Henry SL, Rook KS, Stephens MA, Franks MM. Spousal undermining of older diabetic patients’ disease management. J Health Psychol. 2013;18(12):1550–61.
Fisher L, Chesla CA, Skaff MM, Gilliss C, Mullan JT, Bartz RJ, et al. The family and disease management in Hispanic and European-American patients with type 2 diabetes. Diabetes Care. 2000;23(3):267–72.
Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44(8):763–70.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203.
Sardar P, Udell JA, Chatterjee S, Bansilal S, Mukherjee D, Farkouh ME. Effect of intensive versus standard blood glucose control in patients with type 2 diabetes mellitus in different regions of the world: systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2015;4(5).
Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014;3:1.
Adams OP. The impact of brief high-intensity exercise on blood glucose levels. Diabetes Metab Syndr Obes. 2013;6:113–22.
Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800–5.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.
Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015–21.
Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11–7.
Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia. 2008;51(3):408–16.
Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab. 2014;16(3):193–205.
Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262–7.
Pentakota SR, Rajan M, Fincke BG, Tseng CL, Miller DR, Christiansen CL, et al. Does diabetes care differ by type of chronic comorbidity?: an evaluation of the Piette and Kerr framework. Diabetes Care. 2012;35(6):1285–92.
Bamashmus MA, Gunaid AA, Khandekar R. Regular visits to a diabetes clinic were associated with lower magnitude of visual disability and diabetic retinopathy-a hospital-based historical cohort study in yemen. Diabetes Technol Ther. 2009;11(1):45–50.
Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ. 2011;14(5):646–55.
Capoccia K, Odegard PS, Letassy N. Medication adherence with diabetes medication: a systematic review of the literature. Diabetes Educ. 2016;42(1):34–71.
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.
Brown JB, Valliere Y, McLachlan C, Reichert SM, Webster-Bogaert S, Ratzki-Leewing A, et al. Beyond the Sick Role: The many roles of adults with type 1 and type 2 diabetes in the management of hypoglycemia-the InHypo-DM Study, Canada. Can J Diabetes. 2020;44(7):657–62.
Niedermeier M, Herzog S, Kopp-Wilfling P, Burtscher M, Kopp M. Is the effect of physical activity on quality of life in older adults mediated by social support? Gerontology. 2019;65(4):375–82.
Oka RK, King AC, Young DR. Sources of social support as predictors of exercise adherence in women and men ages 50 to 65 years. Womens Health. 1995;1(2):161–75.
Aggarwal B, Liao M, Allegrante JP, Mosca L. Low social support level is associated with non-adherence to diet at 1 year in the Family Intervention Trial for Heart Health (FIT Heart). J Nutr Educ Behav. 2010;42(6):380–8.
McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17(8):646–9.
Noroozi A, Ghofranipour F, Heydarnia AR, Nabipour I, Shokravi FA. Validity and reliability of the social support scale for exercise behavior in diabetic women. Asia Pac J Public Health. 2011;23(5):730–41.
Naderimagham S, Niknami S, Abolhassani F, Hajizadeh E, Montazeri A. Development and psychometric properties of a new social support scale for self-care in middle-aged patients with type II diabetes (S4-MAD). BMC Public Health. 2012;12:1035.
La Greca AM, Bearman KJ. The diabetes social support questionnaire-family version: evaluating adolescents’ diabetes-specific support from family members. J Pediatr Psychol. 2002;27(8):665–76.
Vijayakumar G, Manghat S, Vijayakumar R, Simon L, Scaria LM, Vijayakumar A, et al. Incidence of type 2 diabetes mellitus and prediabetes in Kerala, India: results from a 10-year prospective cohort. BMC Public Health. 2019;19(1):140.